Basic Information | Post buying leads | Suppliers |
Name |
N-Octylatropinium bromide |
EINECS | N/A |
CAS No. | 5843-82-3 | Density | g/cm3 |
PSA | N/A | LogP | N/A |
Solubility | N/A | Melting Point |
N/A |
Formula | C25H40NO3•Br | Boiling Point | °Cat760mmHg |
Molecular Weight | 482.501 | Flash Point | °C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. When heated to decomposition it emits very toxic fumes of NOx and Br−. See also ATROPINE and BROMIDES. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
N/A |
IUPAC Name: (8-Methyl-8-octyl-8-azoniabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate bromide
Synonyms of N-Octylatropinium bromide (CAS NO.32795-47-4) : 1-alpha-H,5-alpha-H-Tropanium, 3-alpha-hydroxy-8-octyl-, bromide, (-+)-tropate (8CI) ; 8-Octylatropinium bromide ; Atropine-N-octylbromide ; N-n-Octylatropinium bromide ; Endo-(1)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-octyl-8-azoniabicyclo(3.2.1)octane bromide
InChI:InChI=1/C25H40NO3.BrH/c1-3-4-5-6-7-11-16-26(2)21-14-15-22(26)18-23(17-21)29-25(28)24(19-27)20-12-9-8-10-13-20;/h8-10,12-13,21-24,27H,3-7,11,14-19H2,1-2H3;1H/q+1;/p-1
CAS NO:32795-47-4
Molecular Formula:C20H22N2O4
Molecular Weight :354.4
Molecular Structure :
EINECS: 227-435-0
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 102mg/kg (102mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA | Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 813, 1971. |
mouse | LD50 | intravenous | 8200ug/kg (8.2mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: ATAXIA | Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 813, 1971. |
mouse | LD50 | oral | 380mg/kg (380mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 7, Pg. 217, 1957. | |
mouse | LD50 | subcutaneous | 335mg/kg (335mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 7, Pg. 217, 1957. |